Cubist Systematic Strategies, LLC Evolus, Inc. Transaction History

Cubist Systematic Strategies, LLC

  • $15.8 Billion
  • Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Evolus, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 242,042 shares of EOLS stock, worth $2.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
242,042
Previous 338,254 28.44%
Holding current value
$2.88 Million
Previous $3.67 Million 6.84%
% of portfolio
0.02%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$10.66 - $17.48 $1.03 Million - $1.68 Million
-96,212 Reduced 28.44%
242,042 $3.92 Million
Q2 2024

Aug 14, 2024
BUY
$10.45 - $13.76 $189,740 - $249,840
18,157 Added 5.67%
338,254 $3.67 Million
Q1 2024

May 15, 2024
BUY
$9.99 - $14.91 $972,486 - $1.45 Million
97,346 Added 43.7%
320,097 $4.48 Million
Q4 2023

Feb 14, 2024
BUY
$7.6 - $10.53 $789,419 - $1.09 Million
103,871 Added 87.37%
222,751 $2.35 Million
Q3 2023

Nov 14, 2023
BUY
$7.15 - $10.2 $68,454 - $97,654
9,574 Added 8.76%
118,880 $1.09 Million
Q2 2023

Aug 14, 2023
BUY
$7.23 - $10.52 $16,426 - $23,901
2,272 Added 2.12%
109,306 $794,000
Q1 2023

May 15, 2023
BUY
$7.81 - $11.05 $719,957 - $1.02 Million
92,184 Added 620.77%
107,034 $905,000
Q4 2022

Feb 14, 2023
SELL
$6.52 - $8.95 $572,866 - $786,373
-87,863 Reduced 85.54%
14,850 $111,000
Q3 2022

Nov 14, 2022
SELL
$7.76 - $13.72 $14,472 - $25,587
-1,865 Reduced 1.78%
102,713 $827,000
Q2 2022

Aug 15, 2022
BUY
$10.22 - $13.94 $1.03 Million - $1.4 Million
100,554 Added 2498.86%
104,578 $1.21 Million
Q1 2022

May 16, 2022
SELL
$5.22 - $11.78 $286,327 - $646,156
-54,852 Reduced 93.17%
4,024 $45,000
Q4 2021

Feb 14, 2022
SELL
$5.37 - $8.38 $323,376 - $504,635
-60,219 Reduced 50.56%
58,876 $383,000
Q3 2021

Nov 15, 2021
BUY
$7.36 - $13.67 $316,089 - $587,085
42,947 Added 56.4%
119,095 $908,000
Q2 2021

Aug 16, 2021
BUY
$8.42 - $13.96 $544,765 - $903,198
64,699 Added 565.11%
76,148 $963,000
Q1 2021

May 17, 2021
SELL
$3.2 - $16.51 $43,699 - $225,460
-13,656 Reduced 54.4%
11,449 $149,000
Q4 2020

Feb 16, 2021
SELL
$2.92 - $4.84 $1,273 - $2,110
-436 Reduced 1.71%
25,105 $84,000
Q3 2020

Nov 16, 2020
SELL
$3.03 - $5.48 $25,755 - $46,580
-8,500 Reduced 24.97%
25,541 $100,000
Q2 2020

Aug 14, 2020
SELL
$3.53 - $6.17 $86,485 - $151,165
-24,500 Reduced 41.85%
34,041 $180,000
Q1 2020

May 15, 2020
BUY
$3.53 - $12.21 $206,649 - $714,785
58,541 New
58,541 $243,000
Q4 2018

Feb 14, 2019
SELL
$10.57 - $19.29 $1,458 - $2,662
-138 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$17.31 - $29.82 $2,388 - $4,115
138 New
138 $3,000

Others Institutions Holding EOLS

# of Institutions
169
Shares Held
47.8M
Call Options Held
130K
Put Options Held
51K
View Full List

About Evolus, Inc.

EOLS Quotes by TradingView
  • Ticker EOLS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 56,094,800
  • Market Cap $666M
  • Description
  • Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...
More about EOLS
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email